[The role of dopamine receptors in the modulation of mononuclear phagocytes in multiple sclerosis].
A V LopatinaAnastasia SviridovaO O BelousovaU Sh KuzminaMikhail MelnikovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2024)
Targeting of dopaminergic receptors could be considered as an additional mechanism of immunomodulation in MS with both pro- and anti-inflammatory effects on cells of the innate immune system.